Nat Rev Drug Discov 3:711715 Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, Mcguire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T (2015) Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) Analogue semaglutide
Dosage and administration Typical protocols in the literature and clinical practice use subcutaneous injection near the injury site, though oral and intramuscular routes are also used
Engaging with a healthcare provider who considers individual challengessuch as cultural dietary habits, work-related fatigue, or family responsibilitiesmay support more sustainable weight loss outcomes
That means there are no guarantees about product purity, safety, or proper dosing